U.S. Pharma Stock News

Nabors Industries Ltd. has reported past first-quarter 2026 results, with sales of US$783.55 million and revenue of US$786.44 million, but a net loss of US$15.17 million compared with net income a year earlier. Despite higher revenue, the move from earnings per share of US$2.18 diluted a year ago to a diluted loss of US$1.54 highlights rising pressure on profitability. We’ll now explore how Nabors’ shift to a quarterly loss despite higher revenue may influence its previously outlined...

Levi Strauss & Co. (NYSE:LEVI) has rolled out a new conversational analytics platform using Google Cloud’s Looker and Gemini AI. The tool lets more than 2,200 employees query company data in natural language, with reported analytics delivery running about five times faster. This launch is part of Levi Strauss’s broader push to become more data driven and consumer focused across its global operations. For investors watching NYSE:LEVI, this move adds a fresh angle to the story beyond the...

In April 2026, SS&C Technologies Holdings launched SS&C Blue Prism WorkHQ, an agentic automation platform that unifies people, AI agents, APIs, and digital workers under a single, governed control plane to help enterprises run AI-enabled workflows with embedded security, auditability, and compliance. Built on SS&C’s own large-scale use of more than 4,000 digital workers and over 50 AI agents, WorkHQ aims to help customers shift from isolated AI pilots to governed, enterprise-wide automation...

Wondering whether Taiwan Semiconductor Manufacturing stock still offers value after its strong run, or if you might be arriving late to the story? The share price last closed at US$414.15, with returns of 4.6% over 7 days, 19.9% over 30 days, 29.6% year to date, 138.6% over 1 year, 413.9% over 3 years and 306.3% over 5 years. Recent headlines have focused on Taiwan Semiconductor Manufacturing's central role in global chip supply and its position in advanced manufacturing capacity. This...

First quarter results put Herbalife in focus Herbalife (HLF) reported first quarter sales of US$1,317.2 million and net income of US$61.9 million, with earnings per share from continuing operations ahead of the figures reported a year earlier. See our latest analysis for Herbalife. Herbalife's earnings release landed alongside concerns about higher input costs across the personal care sector, and the stock's recent 1 day share price return of an 11.86% decline contrasts with a very large 1...

In the past week, Procore Technologies reported first-quarter 2026 results with revenue of US$359.28 million, a narrower net loss of US$9.1 million, confirmed second-quarter guidance of US$364 million to US$366 million, and full-year 2026 revenue guidance of about US$1.50 billion. The company also completed a US$100.06 million share repurchase, advanced its AI roadmap through acquisitions and a new board appointment, and highlighted AI-enabled products as key drivers of customer adoption and...

If you are wondering whether Grindr stock is priced fairly or if the current level still leaves room for value, you need to look past headlines and into the numbers that shape valuation. Over the last month the share price has moved to US$13.81, with returns of 3.3% over 7 days, 12.4% over 30 days and 3.8% year to date, set against a 43.5% loss over the past year and a 124.2% gain over three years. Recent coverage has focused on Grindr as a listed platform business and how investors are...

Stronger outlook after Q1 earnings surprise ACI Worldwide (ACIW) raised its full year 2026 revenue and adjusted EBITDA guidance after first quarter results exceeded analyst estimates and highlighted double digit growth in both revenue and adjusted EBITDA. The quarter also featured solid contributions from Real Time Payments and Merchant segments, alongside growth in new annual recurring revenue bookings. The upgraded outlook was received positively by investors following the announcement. See...

Atlanticus Holdings Corporation recently reported past first-quarter 2026 results, with net income rising to US$44.18 million and diluted earnings per share from continuing operations at US$2.23, both higher than a year earlier. Management highlighted that strong performance from the Credit as a Service business and the Mercury Financial acquisition were key drivers of the earnings improvement and revenue expansion. With Q1 earnings lifted by the Mercury Financial acquisition and Credit as a...

Minerals Technologies Inc. recently reported first-quarter 2026 results, with sales rising to US$546.9 million from US$491.8 million a year earlier and net income improving to US$36.2 million from a US$144 million loss. The swing from a basic loss per share from continuing operations of US$4.51 to earnings of US$1.17 highlights a sharp turnaround in profitability that may reframe how investors view the company’s earnings power. We’ll now explore how this sharp earnings turnaround, alongside...

Key recent performance context IHS Holding (NYSE:IHS) has drawn investor attention after recent trading that left the stock near US$8.23, with year to date total return of about 12% and 1 year total return around 44%. Over the past month, the stock’s return has been slightly negative, while the past 3 months show a small positive move. This gives investors a mixed short term picture alongside stronger longer term performance. See our latest analysis for IHS Holding. For you as a shareholder,...

If you are wondering whether Apollo Global Management's current share price lines up with its underlying worth, this article walks through the key numbers in plain language. The stock last closed at US$127.79, with a 21.3% gain over the past 30 days, a 0.7% decline over 7 days, a 12.8% decline year to date and a 2.6% decline over the past year. This is set against a 110.8% return over 3 years and a 152.8% return over 5 years. Recent attention on Apollo Global Management has focused on how...

COPT Defense Properties recently reported past first-quarter 2026 results, with revenue rising to US$200.64 million and net income to US$38.56 million, alongside diluted EPS of US$0.34 from continuing operations. Alongside these results, management raised full-year 2026 diluted EPS guidance to US$1.24–US$1.30 and set second-quarter guidance at US$0.31–US$0.33, signaling confidence in the company’s operating outlook. Next, we’ll examine how this higher full-year earnings guidance could...

Recent performance snapshot Box (BOX) has drawn attention after a recent move in its share price, with the stock up about 6% over the past week and around 7% over the past month. See our latest analysis for Box. The recent 1 day share price return of 5.98% and 7 day return of 6.16% sit against a year-to-date share price decline of 10.89%, while the 1 year total shareholder return is down 18.16%. This points to short-term momentum following a weaker period. If this move in Box has you thinking...

Halper Sadeh LLC is investigating e.l.f. Beauty (NYSE:ELF) for potential breaches of fiduciary duty by the company’s officers and directors. The review focuses on whether the board’s decisions have been consistent with obligations to shareholders and could have implications for corporate governance and oversight. The investigation may result in calls for board or policy changes, or potential financial relief, depending on its findings. e.l.f. Beauty operates in the color cosmetics and...

Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR). The vote clears a key milestone for the acquisition and allows the deal process to move toward closing. The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met. For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...

In late April 2026, Porch Group, Inc. reported first-quarter results showing sales of US$121.12 million, up from US$104.75 million a year earlier, while moving from net income of US$8.40 million to a net loss of US$4.71 million. At the same time, Porch Group shifted from earnings per share of US$0.08 to a loss of US$0.04, and followed up with non-deal roadshow presentations in Boston and New York to explain its evolving business model to investors. With first-quarter revenue growth...

Recent performance snapshot for Federal Home Loan Mortgage Federal Home Loan Mortgage (FMCC) has drawn attention after a 1-month return of about 26%, contrasting with a year-to-date decline of roughly 31% and a 3-month decline of nearly 3%. See our latest analysis for Federal Home Loan Mortgage. The share price has recently swung higher, with a 30 day share price return of about 26% from a last close of US$7.14. However, this follows a weaker year to date share price return and contrasts with...

Vistra (VST) has wrapped up FY 2025 with fourth quarter revenue of US$4.6b, Basic EPS of US$0.55 and net income of US$185m, rounding out a trailing twelve month picture that totals US$17.7b in revenue, Basic EPS of US$2.22 and net income of US$752m. Over recent quarters, reported revenue has moved from US$4.0b in Q4 2024 to US$4.6b in Q4 2025, while quarterly Basic EPS has ranged from US$1.16 in Q4 2024 to US$0.55 most recently, setting up a results season where investors are weighing...

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...

If you are wondering whether Planet Labs PBC at around US$35.24 is priced attractively or already baking in big expectations, it helps to step back and look at how the stock has been behaving and what that might imply about value. The share price is around US$35.24, with a 4.7% decline over the last week, roughly flat at 0.2% over the past month, a 72.7% gain year to date, and a very large rise over the past year that is close to 9x, as well as very strong multi year returns. These moves...

NiSource (NYSE:NI) announced new and expanded partnerships with Amazon and Alphabet that are expected to support $1.4 billion in customer savings over 15 years. Alongside these partnerships, the company updated its long term adjusted EPS growth outlook to a range of 9% to 10% through 2033. For investors watching utilities, NiSource stands out with a current share price of $47.02 and a 5 year return of 115.2%. The stock has also returned 21.9% over the past year and 83.7% over 3 years,...

Geopolitical tensions and higher oil prices are pushing up ocean freight costs for Columbia Sportswear, raising questions about future gross margins. Renewed U.S. Iran frictions are contributing to more expensive international shipping, which could affect sourcing and distribution for Columbia's global business. These supply chain pressures come as investors focus on how apparel companies handle external cost shocks alongside consumer demand trends. Columbia Sportswear (NasdaqGS:COLM) is...